Sqlogulhtbmtvop3euhq oxpharm

Oxford PharmaGenesis Ltd

Oxford, GB

Oxford PharmaGenesis is a HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups.

Founded in 1998, Oxford PharmaGenesis is proud to be a leading independently owned consultancy in a sector increasingly populated by corporate communications conglomerates.

Now employing more than 150 dedicated HealthScience experts in offices in Oxford, London, Cardiff, Basel and Philadelphia, Oxford PharmaGenesis is a preferred supplier to 7 of the top 10 global pharmaceutical companies. Our diverse client list comprises over 50 healthcare organizations, including specialist devices, diagnostics and nutraceuticals companies, and professional societies, patient groups and academic institutions.

Selected Publications

Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study. Gattrell W,... Show more »

Oxford PharmaGenesis is a HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups.

Founded in 1998, Oxford PharmaGenesis is proud to be a leading independently owned consultancy in a sector increasingly populated by corporate communications conglomerates.

Now employing more than 150 dedicated HealthScience experts in offices in Oxford, London, Cardiff, Basel and Philadelphia, Oxford PharmaGenesis is a preferred supplier to 7 of the top 10 global pharmaceutical companies. Our diverse client list comprises over 50 healthcare organizations, including specialist devices, diagnostics and nutraceuticals companies, and professional societies, patient groups and academic institutions.

Selected Publications

Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study. Gattrell W, Hopewell S, Young K, Farrow P, White R, Wager E, Winchester CC. BMJ Open 2016;6:e010329.
- Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia. Gouni-Berthold I, Descamps OS, Fraass U, Hartfield E, Allcott K, Dent R, März W. Br J Clin Pharmacol 2016;82:1412–1443.
- Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review. Pfeil AM, Allcott K, Pettengell R, von Minckwitz G, Schwenkglenks M, Szabo Z. Support Care Cancer 2015;23:525–45
- Journal choice: which factors do you value when submitting a manuscript? O’Regan N, Desson A, Hill C, Panayi A, Winchester CC, Baronikova S. Curr Med Res Opin 2016;32(Suppl 1):S16–17. Presented at the 12th International Meeting of the International Society of Medical Publication Professionals, National Harbor, 11–13 April 2016
- Real world evidence publications: preliminary survey of experience, attitudes and understanding in ISMPP members. White R, Male G, Koder T. Curr Med Res Opin 2016;32(Suppl 1):S12. Presented at the 12th International Meeting of the International Society of Medical Publication Professionals, National Harbor, 11–13 April 2016.
- Use of Twitter and other social media to disseminate specialist clinical research: analysis using Altmetric Scott C, Young F, Farrow P. Curr Med Res 2015;31(S9):S18 [poster 24]. Presented at the 11th Annual Meeting of the International Society of Medical Publication Professionals, 27–29 April 2015.

« Show less

Oxford PharmaGenesis Ltd has not listed any services.

Ask A Question Find what you're looking for? If not, you can ask this lab a question:
Health Economic Modeling
Price on request
Request a quote for more information about this service.
Real-World Evidence (RWE) Studies
Price on request
Request a quote for more information about this service.
Medical and Scientific Communications
Price on request

Our approach to medical communications is straightforward: ensure that the right evidence reaches the right audiences at the right time.

For your product to flourish, we believe that effective HealthScience communication solutions need to be seeded at all stages of the product life cycle and to be professionally delivered... Show more »

Our approach to medical communications is straightforward: ensure that the right evidence reaches the right audiences at the right time.

For your product to flourish, we believe that effective HealthScience communication solutions need to be seeded at all stages of the product life cycle and to be professionally delivered through appropriate traditional or digital channels. The communication focus for your product will of course evolve with time, but whether it is advocacy development pre-launch or medical expert meetings post-launch, we can support all of your medical communications needs so that your product reaches its full potential.

Key deliverables

  • Stakeholder identification and mapping
  • Advisory boards, expert meetings and events, satellite symposia
  • Medical and scientific liaison materials, internal communications
  • Speaker bureaux, hub & spoke regional education programmes
  • Product and disease area training platforms
  • Digital medical education, including app development
  • Product monographs, product websites
  • Patient and caregiver materials
« Show less
Scientific Manuscript Preparation
Price on request

Peer-reviewed publication planning and delivery remains the cornerstone of evidence-based medicine and is essential to all aspects of HealthScience.

While publication practices become more transparent, delivery platforms evolve and demonstrating compliance becomes more complex, one element remains constant – the need to... Show more »

Peer-reviewed publication planning and delivery remains the cornerstone of evidence-based medicine and is essential to all aspects of HealthScience.

While publication practices become more transparent, delivery platforms evolve and demonstrating compliance becomes more complex, one element remains constant – the need to communicate the right evidence to the right audiences at the right time.

Our consultants and writers work directly with authors and clients as part of their core teams, building relationships and understanding their perspectives. Delivering high-quality writing brings satisfaction to our authors, clients and ourselves – contributing to our low staff turnover and assuring continuity for our clients. With over 15 years of experience in publishing evidence across a wide range of therapy areas, Oxford PharmaGenesis has the power to deliver and is dedicated to your success.

Key deliverables

  • Experience in all major therapeutic areas, including industry-leading expertise in rare and orphan diseases
  • Expert publication services
    • Real-world evidence (systematic reviews, database/registry publications)
    • Value demonstration (cost-effectiveness and budget impact models, patient-reported outcomes)
    • Clinical data (primary and secondary manuscripts, congress abstracts and presentations, meta-analyses including indirect treatment comparisons)
  • Global, regional and local strategic publications plans (product and portfolio level)
  • Data analysis and statistical consultancy
  • Innovative digital publications platforms
  • Good publication practice and compliance consultancy
« Show less
Market Access and Commercialization
Price on request

Oxford PharmaGenesis Commercialization Practice applies our unique HealthScience approach to ensure that your go-to-market strategy and launch plans address all of the requirements of the external stakeholders who determine the commercial viability of your product.

We believe that the key to success is to help you to steer the... Show more »

Oxford PharmaGenesis Commercialization Practice applies our unique HealthScience approach to ensure that your go-to-market strategy and launch plans address all of the requirements of the external stakeholders who determine the commercial viability of your product.

We believe that the key to success is to help you to steer the commercialization process by integrating input from all directions. The value of our advice to you is that it is given unrestricted by internal pressures; this assists you in ensuring that there is a genuine need and business case for your asset early in development and in creating the appropriate frameworks within your organization to support activities throughout the product life cycle. Members of our consultancy team have personally been responsible for over 10 major product launches during their time spent in the pharmaceutical industry, and they present at leading business schools in Europe and the USA.

Key deliverables

  • Business development and in-licensing opportunity assessments
  • Stakeholder mapping
  • Brand, portfolio and franchise marketing plans
  • Investor presentations
  • Launch readiness programmes
  • Field force training and communications tools
« Show less
Medical Affairs
Price on request
Request a quote for more information about this service.
Health Economics and Outcomes Research (HEOR)
Price on request
Request a quote for more information about this service.
Project Management, Consulting, & Support Services
Price on request
Request a quote for more information about this service.
Clinical Research
Price on request
Request a quote for more information about this service.
Marketing, Communication & Graphic Design Services
Price on request
Request a quote for more information about this service.
Editorial and Writing Services
Price on request
Request a quote for more information about this service.
Clinical Trials, Consulting, and Management
Price on request
Request a quote for more information about this service.
Business Development & Support Services
Price on request
Request a quote for more information about this service.
Epidemiology, HEOR, and Post-Authorization Studies
Price on request
Request a quote for more information about this service.

Oxford PharmaGenesis Ltd has not received any ratings.

Be the first to endorse Oxford PharmaGenesis Ltd

Endorse this lab